Back to top
more

BioTechne Corp (TECH)

(Delayed Data from NSDQ)

$75.96 USD

75.96
649,382

-0.46 (-0.60%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $75.96 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks News

Techne (TECH) Beats Q3 Earnings and Revenue Estimates

Techne (TECH) delivered earnings and revenue surprises of 7% and 2.47%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

HZNP or TECH: Which Is the Better Value Stock Right Now?

HZNP vs. TECH: Which Stock Is the Better Value Option?

Should Vanguard SmallCap Growth ETF (VBK) Be on Your Investing Radar?

Style Box ETF report for VBK

Gilead Sciences (GILD) Beats Q1 Earnings and Revenue Estimates

Gilead (GILD) delivered earnings and revenue surprises of 19.77% and 6.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

Should Vanguard SmallCap ETF (VB) Be on Your Investing Radar?

Style Box ETF report for VB

Should Vanguard SmallCap Growth ETF (VBK) Be on Your Investing Radar?

Style Box ETF report for VBK

VRTX vs. TECH: Which Stock Should Value Investors Buy Now?

VRTX vs. TECH: Which Stock Is the Better Value Option?

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

Techne (TECH) delivered earnings and revenue surprises of 3.30% and 0.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Techne (TECH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

Should Vanguard SmallCap ETF (VB) Be on Your Investing Radar?

Style Box ETF report for VB

Should Vanguard SmallCap Growth ETF (VBK) Be on Your Investing Radar?

Style Box ETF report for VBK

Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

Should Vanguard SmallCap ETF (VB) Be on Your Investing Radar?

Style Box ETF report for VB

3 Reasons Why Growth Investors Shouldn't Overlook Techne (TECH)

Techne (TECH) is well positioned to outperform the market, as it exhibits above-average growth in financials.

REGN vs. TECH: Which Stock Is the Better Value Option?

REGN vs. TECH: Which Stock Is the Better Value Option?

Should SPDR S&P 400 Mid Cap Growth ETF (MDYG) Be on Your Investing Radar?

Style Box ETF report for MDYG

Should iShares Core S&P MidCap ETF (IJH) Be on Your Investing Radar?

Style Box ETF report for IJH

Techne (TECH) Q1 Earnings and Revenues Top Estimates

Techne (TECH) delivered earnings and revenue surprises of 3.39% and 1.32%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Techne (TECH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Vanguard SmallCap Growth ETF (VBK) Be on Your Investing Radar?

Style Box ETF report for VBK